Olamide Olawoyin
Instructor/Lecturer · Yale-New Haven Hospital
Credentials: · ·
History
Present
- 2022–2026
- 2018–2022
- 2014–2018
Research
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Cell · 2021 · 356 citations
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Cancer Discovery · 2021 · 88 citations
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
The Journal of Experimental Medicine · 2020 · 60 citations
- BP
5 papers · 5 as a resident
4 papers
- SL
4 papers · 4 as a resident
- SM
4 papers · 1 as a resident
- TA
4 papers
3 papers
- AC
3 papers · 3 as a fellow
- FC
3 papers · 1 as a resident
